CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
Europe - Euronext Oslo - OSL:CONTX - SE0014731154 - Common Stock
3.99 NOK
0 (0%)
We assign a fundamental rating of 6 out of 10 to CONTX. CONTX was compared to 11 industry peers in the Health Care Technology industry. CONTX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CONTX has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CONTX was profitable.
In the past year CONTX had a positive cash flow from operations.
Of the past 5 years CONTX 4 years were profitable.
CONTX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CONTX has a Return On Assets of 7.66%. This is in the better half of the industry: CONTX outperforms 63.64% of its industry peers.
CONTX has a better Return On Equity (10.25%) than 63.64% of its industry peers.
CONTX has a better Return On Invested Capital (8.96%) than 72.73% of its industry peers.
CONTX had an Average Return On Invested Capital over the past 3 years of 36.72%. This is significantly above the industry average of 9.28%.
The 3 year average ROIC (36.72%) for CONTX is well above the current ROIC(8.96%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROIC | 8.96% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
CONTX's Profit Margin of 7.86% is fine compared to the rest of the industry. CONTX outperforms 63.64% of its industry peers.
In the last couple of years the Profit Margin of CONTX has grown nicely.
Looking at the Operating Margin, with a value of 9.33%, CONTX is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
CONTX's Operating Margin has improved in the last couple of years.
CONTX's Gross Margin of 97.46% is amongst the best of the industry. CONTX outperforms 90.91% of its industry peers.
CONTX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
The number of shares outstanding for CONTX remains at a similar level compared to 1 year ago.
The number of shares outstanding for CONTX remains at a similar level compared to 5 years ago.
CONTX has a worse debt/assets ratio than last year.
2.2 Solvency
CONTX has a debt to FCF ratio of 1.49. This is a very positive value and a sign of high solvency as it would only need 1.49 years to pay back of all of its debts.
CONTX has a better Debt to FCF ratio (1.49) than 63.64% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that CONTX is not too dependend on debt financing.
CONTX's Debt to Equity ratio of 0.07 is fine compared to the rest of the industry. CONTX outperforms 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Altman-Z | N/A |
ROIC/WACC1.27
WACC7.08%
2.3 Liquidity
A Current Ratio of 4.12 indicates that CONTX has no problem at all paying its short term obligations.
The Current ratio of CONTX (4.12) is better than 90.91% of its industry peers.
CONTX has a Quick Ratio of 4.07. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 4.07, CONTX belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.32% over the past year.
Measured over the past years, CONTX shows a very strong growth in Earnings Per Share. The EPS has been growing by 40.02% on average per year.
The Revenue has grown by 12.19% in the past year. This is quite good.
Measured over the past years, CONTX shows a small growth in Revenue. The Revenue has been growing by 7.78% on average per year.
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-21.24%
3.2 Future
CONTX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -13.34% yearly.
Based on estimates for the next years, CONTX will show a decrease in Revenue. The Revenue will decrease by -1.19% on average per year.
EPS Next Y-28.88%
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
EPS Next 5Y-13.34%
Revenue Next Year-5.88%
Revenue Next 2Y-11.72%
Revenue Next 3Y-6.27%
Revenue Next 5Y-1.19%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 8.67, the valuation of CONTX can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of CONTX indicates a rather cheap valuation: CONTX is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.54, CONTX is valued rather cheaply.
CONTX is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.67 | ||
| Fwd PE | N/A |
4.2 Price Multiples
CONTX's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CONTX is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 48.15 | ||
| EV/EBITDA | 11.58 |
4.3 Compensation for Growth
CONTX has an outstanding profitability rating, which may justify a higher PE ratio.
CONTX's earnings are expected to decrease with -35.39% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
5. Dividend
5.1 Amount
CONTX has a Yearly Dividend Yield of 4.18%, which is a nice return.
CONTX's Dividend Yield is rather good when compared to the industry average which is at 4.12. CONTX pays more dividend than 81.82% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, CONTX pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
OSL:CONTX (12/12/2025, 7:00:00 PM)
3.99
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap308.71M
Revenue(TTM)132.19M
Net Income(TTM)9.36M
Analysts40
Price Target4.08 (2.26%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-124.27%
Min EPS beat(2)-148.54%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.12%
Min Revenue beat(2)-29.34%
Max Revenue beat(2)-4.91%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-20%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)-104.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-11.52%
Revenue NY rev (3m)-14.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.67 | ||
| Fwd PE | N/A | ||
| P/S | 2.38 | ||
| P/FCF | 48.15 | ||
| P/OCF | 20.77 | ||
| P/B | 3.1 | ||
| P/tB | 3.2 | ||
| EV/EBITDA | 11.58 |
EPS(TTM)0.46
EY11.53%
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)0.08
FCFY2.08%
OCF(TTM)0.19
OCFY4.81%
SpS1.68
BVpS1.29
TBVpS1.25
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.65
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROCE | 11.34% | ||
| ROIC | 8.96% | ||
| ROICexc | 31.76% | ||
| ROICexgc | 35.3% | ||
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% | ||
| FCFM | 4.93% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexgc growth 3Y-39.35%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 96.94% | ||
| Cap/Sales | 6.51% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.3% | ||
| Profit Quality | 62.81% | ||
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 | ||
| Altman-Z | N/A |
F-Score5
WACC7.08%
ROIC/WACC1.27
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-28.88%
EPS Next 2Y-42.29%
EPS Next 3Y-35.39%
EPS Next 5Y-13.34%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-21.24%
Revenue Next Year-5.88%
Revenue Next 2Y-11.72%
Revenue Next 3Y-6.27%
Revenue Next 5Y-1.19%
EBIT growth 1Y-64.61%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-25%
EBIT Next 3Y6.69%
EBIT Next 5YN/A
FCF growth 1Y-82.88%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-68.39%
OCF growth 3Y51.49%
OCF growth 5Y5.6%
CONTEXTVISION AB / CONTX.OL FAQ
What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CONTX.OL.
What is the valuation status of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a valuation rating of 4 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Fairly Valued.
How profitable is CONTEXTVISION AB (CONTX.OL) stock?
CONTEXTVISION AB (CONTX.OL) has a profitability rating of 8 / 10.
How financially healthy is CONTEXTVISION AB?
The financial health rating of CONTEXTVISION AB (CONTX.OL) is 7 / 10.
Can you provide the expected EPS growth for CONTX stock?
The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -28.88% in the next year.